Vestmark Advisory Solutions »

Crispr Therapeutics shares owned by Vestmark Advisory Solutions

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Vestmark Advisory Solutions from 13F filings

Historical chart of Vestmark Advisory Solutions investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Vestmark Advisory Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Vestmark Advisory Solutions

Quarter filed Position value Share count Share price at filing
2023-12-31 $11M 173k 62.60

More positions owned by Vestmark Advisory Solutions

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
J P Morgan Exchange Traded F Betabuildrs Us (BBUS)
Ishares Tr Core Div Grwth (DGRO)
Dimensional Etf Trust Global Cr Etf (DGCB)
Ishares Tr Intl Div Grwth (IGRO)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
J P Morgan Exchange Traded F Betabuilders I (BBIN)
Spdr Ser Tr Prtflo S&p500 Hi (SPYD)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Coinbase Global Com Cl A (COIN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Dimensional Etf Trust Global Core Plus (DFGP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)

View all positions for Vestmark Advisory Solutions

Top funds holding Crispr Therapeutics

ARK Investment Management
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Citadel Advisors
Vanguard Group
NEA Management Company
Caption Management
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Dimensional Fund Advisors
Voloridge Investment Management
Ikarian Capital
Charles Schwab Investment Management

View all funds holding Crispr Therapeutics